Cart
0

COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015 - 2022

Get 20% Free Customization In This Report
LI_16579
Pages: 158
Aug 2016 | 7209 Views
 
Author's : Deepa Tatkare
Tables: 47
Charts: 69
 

COPD and Asthma Devices Market Overeview:

COPD and Asthma Devices Market to Reach $41,355.2 Million, Globally, by 2022. COPD and asthma devices, namely inhalers and nebulizers, are the most dynamic solution for the treatment of patients suffering from chronic obstructive pulmonary disease and asthma. The global COPD and asthma devices market is categorized, based on the types of devices, into inhalers and nebulizers. These two devices are frequently used in the treatment of COPD and asthma. Inhalers are small handheld devices that are used to deliver medicines for the treatment of chronic obstructive pulmonary disease (COPD). Presently, there are three types of inhalers available in the market such as dry powder inhalers, metered dose inhalers, and soft mist inhalers. In addition, inhalers are available in two forms, i.e. rescue inhalers and maintenance inhalers. Inhalation route is the fastest and most effective method of delivering medications to the respiratory system during treatment of COPD and asthma. This type of treatment is known as combination therapy, in which a combination of two control medications is delivered through an inhaler.

The global COPD and asthma devices market is likely to grow steadily because factors such as steady increase in incidence of pulmonary disorders and improper lifestyle (smoking habits) are expected to have a sustained effect on the market during the extended forecast period. The market is likely to grow steadily in the emerging economies owing to the high cost barriers for refilling these devices.

Market Segmentation Review:

The global COPD and asthma devices market comprises two key segments namely, product type and geography. The product type market considered in this report includes Inhalers which comprises of Drug Powder Inhalers, Metered Dose Inhalers & Soft Mist Inhalers. Based on geography, the COPD and Asthma Devices is categorized into North America, Europe, Asia Pacific & LAMEA. North America was the leading region in the market in 2015, and expected to continue leading market thoughout analysis period.

World COPD and Asthma Devices Market Segmentation Review

 Get more information on this report : Request Sample Pages

Source: AMR Analysis

Key factors impacting the market:

The key players in the market face price competition from the local device manufacturers. In the developing and underdeveloped regions, the local manufacturers sell these COPD and asthma devices at lower prices owing to the availability of cheap raw materials, thus restraining growth of the market (in terms of value). COPD and asthma treatment is a long and expensive process; affordability of the treatment cost is a core-restraining factor for seeking treatment (services and products/devices). Reimbursements are unavailable or inadequate in many of the developing and underdeveloped nations. Rising percentage of smokers is expected to significantly affect the adoption of these devices by 2020. Portable devices are the only alternative for nebulizer treatments in COPD and asthma. The usage of the portable devices is likely to grow in the near future owing to the inherent benefits of these devices. By 2020, the impact of pollution is likely to worsen worldly, owing to the industrialization of areas and rising number of vehicles. Currently, government initiatives and rising healthcare expenditure have a notable impact on the COPD and asthma devices market, which would enhance over the analysis period. SMIs deliver metered dosage of medication as a soft mist. Rising adoption of these devices is likely to drive the growth of COPD and asthma devices market by 2020. Also, the Patent expiration of popular drugs is a key opportunity for the market due to the increasing availability of generic drugs that can be incorporated in COPD and asthma devices.

TOP FACTORS IMPACTING GLOBAL COPD AND ASTHMA DEVICES MARKET, 2015 - 2022

TOP FACTORS IMPACTING WORLD COPD AND ASTHMA DEVICES MARKET, 2015 - 2022

 Get more information on this report : Request Sample Pages

Top winning strategies:

Product launch, agreement and collaboration are the top three winning strategies adopted by key players in the COPD and Asthma Devices Market. Key players profiled in this report are, Novartis AG, GlaxoSmithKline, Boehringer Ingelheim GmbH, and AstraZeneca Plc. Most of these companies belong to the North American and European regions with strong distribution network globally. The major players in the COPD asthma devices market are focusing majorly on the product innovation and approvals strategy. The prominent players in the market are also undergoing collaborations and expansion which will further propel the growth of the COPD asthma devices market. 

TOP WINNING STRATEGIES, 2012 - 2016

TOP WINNING STRATEGIES, 2012 - 2016

 Get more information on this report : Request Sample Pages
 

Government regulations in Europe and the U.S.:

Governments across each country have implemented regulations for the production, standardization, and utilization of COPD devices. These devices are divided into categories such as Class-I, Class-II, Class-III, and Class-IV, depending upon the level of risk associated with it. In Europe, the European commission is the regulatory authority that regulates the Medical Device Directories (MDD), which harmonize medical devices in European Union. In the U.S., it is mandatory for the manufacturers and initial distributors of medical devices to register their establishments with FDA and list their products. Communaute Europeenne (CE) marking certification is mandatory for all the medical devices sold in Europe. This certification requires only proof of safety, whereas the U.S. FDA requires evidence of both safety and efficacy of a device.

COPD and Asthma Devices Market

 Get more information on this report : Request Sample Pages

COPD AND ASTHMA DEVICES MARKET KEY BENEFITS

This report offers the following benefits in particular:

  • The market estimations in this report are based on high-end analysis of the key segments from 2015 to 2022.
  • Extensive analysis of the COPD and asthma devices market, by product, helps in understanding the various types of devices used for the treatment of respiratory conditions. 
  • This report provides comprehensive analysis of factors that drive and restrict growth of the COPD and asthma devices market.
  • Porter’s Five Forces model provides an in-depth analysis of the bargaining power of buyers and suppliers, threats of new entrants and substitutes, and competition among the key market players. 
  • Competitive intelligence highlights the business practices adopted by leading market players across various geographies.
  • SWOT analyses of market players enable the study of the internal environment and strategies adopted by them.

COPD AND ASTHMA DEVICES MARKET SEGMENTATION

BY PRODUCT TYPE

  • Inhalers
    • Drug Powder Inhalers (DPIs)
    • Metered Dose Inhalers (MDIs)
    • Soft Mist Inhalers (SMIs)
  • Nebulizers
    • Compressor Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers

BY GEOGRAPHY

  • North America 
    • USA
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
    • Others 
  • LAMEA
    • Latin America
    • Middle East
    • Africa
 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Primary research
1.4.2 Secondary Research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond what to expect by 2027

2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.2.3 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of buyers (High)
3.3.2 Bargaining power of suppliers (Low to Moderate)
3.3.3 Threat of new entrants (Low)
3.3.4 Threat of substitutes (High)
3.3.5 Intense competitive rivalry

3.4 Value chain analysis
3.5 Market share analysis, 2015
3.6 Government regulations

3.6.1 COPD devices regulations in Europe and in the U.S.
3.6.2 COPD devices regulations in Asia-Pacific

3.7 Drivers

3.7.1 Daily exposure to environmental pollution
3.7.2 Increase in population susceptible to indoor air pollutants
3.7.3 Portability of the drug delivery devices
3.7.4 Increasing population of Active smokers
3.7.5 Rising government initiatives

3.8 Restraints

3.8.1 Increasing price competition and deterioration of material quality
3.8.2 Overall high cost of asthma treatment is a challenge for the patients
3.8.3 Incompetent reimbursement support

3.9 Opportunities

3.9.1 Patent expiration for blockbuster drugs
3.9.2 Soft Mist Inhalers (SMIs): future growth driver

Chapter: 4 WORLD COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE

4.1 Inhalers

4.1.1 Drug powdered inhalers (DPIs)

4.1.1.1 Key market trends
4.1.1.2 Key growth factors
4.1.1.3 Market size and forecast

4.1.2 Metered dose inhalers (MDIs)

4.1.2.1 Key market trends
4.1.2.2 Key growth factors
4.1.2.3 Market size and forecast

4.1.3 Soft mist inhalers

4.1.3.1 Key market trends
4.1.3.2 Key growth factors
4.1.3.3 Market size and forecast

4.2 Nebulizers

4.2.1 Compressor nebulizers
4.2.2 Ultrasonic nebulizers
4.2.3 Mesh nebulizers

Chapter: 5 WORLD COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY

5.1 Introduction
5.2 Market size and forecast
5.3 North America

5.3.1 Key market trends
5.3.2 Market size and forecast
5.3.3 U.S

5.3.3.1 Market size and forecast

5.3.4 Canada

5.3.4.1 Market size and forecast

5.3.5 Mexico

5.3.5.1 Market size and forecast

5.4 Europe

5.4.1 Key market trends
5.4.2 Market size and forecast
5.4.3 UK

5.4.3.1 Market size and forecast

5.4.4 France

5.4.4.1 Market size and forecast

5.4.5 Germany

5.4.5.1 Market size and forecast

5.4.6 Italy

5.4.6.1 Market size and forecast

5.4.7 Russia

5.4.7.1 Market size and forecast

5.4.8 Others European countries

5.4.8.1 Market size and forecast

5.5 Asia-Pacific

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.5.4 India

5.5.4.1 Market size and forecast

5.5.5 China

5.5.5.1 Market size and forecast

5.5.6 Japan

5.5.6.1 Market size and forecast

5.5.7 Australia

5.5.7.1 Market size and forecast

5.5.1 Others

5.5.1.1 Market size and forecast

5.6 LAMEA

5.6.1 Key market trends
5.6.2 Market size and forecast
5.6.3 Brazil

5.6.3.1 Market size and forecast

5.6.4 Argentina

5.6.4.1 Market size and forecast

5.6.5 Colombia

5.6.5.1 Market size and forecast

5.6.6 Saudi Arabia

5.6.6.1 Market size and forecast

5.6.7 Turkey

5.6.7.1 Market size and forecast

5.6.8 Others

5.6.8.1 Market size and forecast

Chapter: 6 COMPANY PROFILES

6.1 Glaxosmithcline PLC

6.1.1 Company overview
6.1.2 Operating business segment overview
6.1.3 Business performance
6.1.4 Key strategies move and development
6.1.5 SWOT analysis

6.2 Novartis AG

6.2.1 Company overview
6.2.2 Operating business segment overview
6.2.3 Business performance
6.2.4 Key strategies and development
6.2.5 SWOT analysis

6.3 Merck & Company

6.3.1 Operating business segment overview
6.3.2 Business performance
6.3.3 SWOT analysis

6.4 Philips Healthcare (Division of Royal Philips Company)

6.4.1 Company overview
6.4.2 Business performance
6.4.3 Strategic moves and developments
6.4.4 SWOT analysis

6.5 AstraZeneca Plc.

6.5.1 Company overview
6.5.2 Operating business segment overview
6.5.3 Business performance
6.5.4 Strategic moves and developments
6.5.5 SWOT analysis

6.6 3M Healthcare

6.6.1 Company overview
6.6.2 Business performance
6.6.3 Strategy move and development
6.6.4 SWOT analysis

6.7 GF Health Products

6.7.1 Company overview
6.7.2 Strategic moves and developments
6.7.3 SWOT analysis

6.8 Sunovion Pharmaceuticals Inc.

6.8.1 Company overview
6.8.2 Operating business segment overview
6.8.3 Business performance
6.8.4 Strategic moves and developments
6.8.5 SWOT analysis

6.9 Smith Medicals, Inc.

6.9.1 Company overview
6.9.2 Business performance
6.9.3 SWOT analysis

6.10 Baxter International

6.10.1 Company overview
6.10.2 Operating business segment overview
6.10.3 Business performance
6.10.4 SWOT analysis

6.11 Boehringer Ingelheim GmbH

6.11.1 Company overview
6.11.2 Operating business segment overview
6.11.3 Business performance
6.11.4 Key strategies and developments
6.11.5 SWOT analysis

List of Figures

FIG. 1 IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO, 2022-2027
FIG. 2 IMPACT ANALYSIS OF RAPID GROWTH SCENARIO, 20222027
FIG. 3 IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO, 20222027
FIG. 4 TOP FACTORS IMPACTING WORLD COPD AND ASTHMA DEVICES MARKET, 20152022
FIG. 5 TOP INVESTMENT POCKETS OF WORLD COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPES
FIG. 6 TOP WINNING STRATEGY IN COPD AND ASTHMA DEVICES MARKET, 20122016
FIG. 7 TOP WINNING STRATEGIES, BY APPLICATION, 20122016
FIG. 8 PORTERS FIVE FORCES ANALYSIS OF WORLD COPD AND ASTHMA DEVICES MARKET
FIG. 9 VALUE CHAIN ANALYSIS OF WORLD COPD AND ASTHMA DEVICES
FIG. 10 MARKET SHARE ANALYSIS OF COPD AND ASTHMA DEVICES MARKET, 2015 (%)
FIG. 11 COPD AND ASTHMA INCIDENCE IN GREAT BRITAIN, 2003-2013
FIG. 12 U.S. ASTHMA AND COPD DEVICES MARKET, 20152022 ($MILLION)
FIG. 13 CANADA COPD AND ASTHMA DEVICES MARKET, 20152022 ($MILLION)
FIG. 14 MEXICO COPD AND ASTHMA DEVICES MARKET, 20152022 ($MILLION)
FIG. 15 UK COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 16 FRANCE COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 17 GERMANY COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 18 ITALY COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 19 RUSSIA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 20 REST OF EUROPEAN COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 21 INDIA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 22 CHINA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 23 JAPAN COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 24 AUSTRALIA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 25 REST OF APAC COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)
FIG. 26 BRAZIL COPD AND ASTHMA MARKET, 20152022 ($MILLION)
FIG. 27 ARGENTINA COPD AND ASTHMA MARKET, 20152022 ($MILLION)
FIG. 28 COLOMBIA COPD AND ASTHMA MARKET, 20152022 ($MILLION)
FIG. 29 SAUDI ARABIA COPD AND ASTHMA MARKET, 20152022 ($MILLION)
FIG. 30 TURKEY COPD AND ASTHMA MARKET, 20152022 ($MILLION)
FIG. 31 OTHERS COPD AND ASTHMA MARKET, 20152022 ($MILLION)
FIG. 32 GLAXOSMITHKLINE PLC, REVENUE 2013-2015 ($MILLION)
FIG. 33 GLAXOSMITHKLINE PLC, REVENUE BY GEOGRAPHY 2015 (%)
FIG. 34 GLAXOSMITHKLINE PLC REVENUE BY BUSINESS SEGMENTS, 2015 (%)
FIG. 35 SWOT ANALYSIS OF GLAXOSMITHKLINE PLC
FIG. 36 NOVARTIS AG REVENUE 2013-2015 ($MILLION)
FIG. 37 NOVARTIS AG REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 38 NOVARTIS AG REVENUE BY BUSINESS SEGMENTS, 2015 (%)
FIG. 39 SWOT ANALYSIS OF NOVARTIS AG
FIG. 40 MERCK & CO. REVENUE, 2013-2015 ($MILLION)
FIG. 41 MERCK REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 42 MERCK REVENUE BY BUSINESS UNITS, 2015 (%)
FIG. 43 SWOT ANALYSIS OF MERCK
FIG. 44 PHILIPS REVENUE, 2013-2015, ($MILLION)
FIG. 45 PHILIPS REVENUE, BY BUSINESS UNITS, 2015 (%)
FIG. 46 SWOT ANALYSIS OF PHILIPS HEALTHCARE
FIG. 47 ASTRAZENECA INC REVENUE, 2013-2015 ($MILLION)
FIG. 48 ASTRAZENECA REVENUE, BY SEGMENT 2015 (%)
FIG. 49 ASTRAZENECA REVENUYE BY GEOGRAPHY, 2013 (%)
FIG. 50 ASTRAZENECA INC. SWOT ANALYSIS
FIG. 51 3M REVENUE, 2013-2015 ($MILLION)
FIG. 52 3M REVENUE BY BUSINESS SEGMENTS, 2015 (%)
FIG. 53 3M REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 54 SWOT ANALYSIS OF 3M
FIG. 55 SWOT ANALYSIS OF GF HEALTH PRODUCTS
FIG. 56 SUNOVION REVENUE, 2012-2015 ($MILLION)
FIG. 57 SUNOVION REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 58 SWOT ANALYSIS OF SUNOVION INC.
FIG. 59 SMITH MEDICAL INC. REVENUE, 2013-2015 ($MILLION)
FIG. 60 SMITH MEDICAL INC. REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 61 SMITH MEDICAL INC- SWOT ANALYSIS
FIG. 62 BAXTER INTERNATIONAL REVENUE, 2013-2015 ($MILLION)
FIG. 63 BAXTER INTERNATIONAL REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 64 BAXTER INTERNATIONAL REVENUE BY BUSINESS SEGMENTS, 2015 (%)
FIG. 65 SWOT ANALYSIS OF BAXTER INTERNATIONAL
FIG. 66 BOEHRINGER INGELHEIM REVENUE, 2013-2015 ($MILLION)
FIG. 67 BOEHRINGER INGELHEIM REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 68 BOEHRINGER INGELHEIM REVENUE BY BUSINESS SEGMENTS, 2015 (%)
FIG. 69 SWOT ANALYSIS OF BOEHRINGER INGELHEIM GMBH

List of Tables

TABLE 1 WORLD COPD AND ASTHMA DEVICES MARKET, MODERATE GROWTH SCENARIO BY GEOGRAPHY, 20222027 ($MILLION)
TABLE 2 WORLD COPD AND ASTHMA DEVICES MARKET, RAPID GROWTH SCENARIO BY GEOGRAPHY, 20222027 ($MILLION)
TABLE 3 WORLD COPD AND ASTHMA DEVICES MARKET, DIMINISHING GROWTH SCENARIO BY GEOGRAPHY, 20222027 ($MILLION)
TABLE 4 ADVANTAGES AND DISADVANTAGES OF MARKETED PORTABLE INHALER DEVICES
TABLE 5 PERCENTAGE OF SMOKER POPULATION BY ETHNICITY, 2012
TABLE 6 TOP 10 COUNTRIES HEALTHCARE EXPENDITURE, 2013
TABLE 7 WORLD COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE, 20152022, ($MILLION)
TABLE 8 RESCUE INHALERS VS MAINTENANCE INHALERS
TABLE 9 COMMON TYPES OF INHALERS
TABLE 10 TOP 10 COPD INHALERS
TABLE 11 WORLD COPD AND ASTHMA INHALERS MARKET, BY TYPE, 2015-2022, ($MILLION)
TABLE 12 WORLD COPD AND ASTHMA INHALERS MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 13 DRY POWDER INHALERS
TABLE 14 WORLD DRY POWDER INHALERS (DPI) MARKET, BY GEOGRAPHY, 20152022, $MILLION
TABLE 15 TYPES OF METERED DOSE INHALERS (MDIS)
TABLE 16 WORLD METERED DOSE INHALERS (MDI) MARKET, BY GEOGRAPHY, 20152022, $MILLION
TABLE 17 WORLD SOFT MIST INHALERS (SMI) MARKET, BY GEOGRAPHY,
TABLE 18 2015-2022, $MILLION
TABLE 19 COMMERCIALIZED NEBULIZERS AND ITS COST
TABLE 20 WORLD NEBULIZERS MARKET, BY TYPE, 20152022, ($MILLION)
TABLE 21 WORLD NEBULIZERS MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 22 WORLD COMPRESSOR NEBULIZERS MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 23 WORLD ULTRASONIC NEBULIZERS MARKET, BY GEOGRAPHY, 20152022, ($MILLION)
TABLE 24 WORLD MESH NEBULIZERS MARKET, BY GEOGRAPHY, 20152022, ($MILLION)
TABLE 25 WORLD COPD AND ASTHMA DEVICES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 26 NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY TYPE, 2015-2022 ($MILLION)
TABLE 27 EUROPE COPD AND ASTHMA DEVICES MARKET, BY TYPE; 20152022 ($MILLION)
TABLE 28 ASIA-PACIFIC COPD DEVICES MARKET, BY TYPE, 2015-2022 ($MILLION)
TABLE 29 LAMEA COPD AND ASTHMA MARKET, BY TYPE, 2015-2022 ($MILLION)
TABLE 30 GLAXOSMITHKLINE PLC SNAPSHOT
TABLE 31 GLAXOSMITHKLINE PLC OPERATING SEGEMENTS
TABLE 32 NOVARTIS AG SNAPSHOT
TABLE 33 NOVARTIS AG OPERATING SEGEMENTS
TABLE 34 MERCK COMPANY SNAPSHOT
TABLE 35 MERCK OPERATING SEGEMENTS
TABLE 36 PHILIPS HEALTHCARE BUSINESS SNAPSHOT
TABLE 37 ASTRAZENECA INC. SNAPSHOT
TABLE 38 ASTRAZENACA INC. OPERATING SEGMENT OVERVIEW
TABLE 39 3M SNAPSHOT
TABLE 40 GF HEALTH PRODUCTS SNAPSHOT
TABLE 41 SUNOVION SNAPSHOT
TABLE 42 SUNOVION OPERATING SEGEMENTS
TABLE 43 SMITH MEDICAL INC SNAPSHOT
TABLE 44 BAXTER SNAPSHOT
TABLE 45 BOEHRINGER INGELHEIM GMBH SNAPSHOT
TABLE 46 BOEHRINGER INGELHEIM GMBH OPERATING SEGEMENTS

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
COPD and Asthma Devices Market- Global Opportunity Analysis and Industry Forecasts, 2015 - 2022

  • Online Only
  • $4266 $3840
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4739 $4266
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5639 $4794
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6773 $5419
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9445 $7084
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo